Key Insights

Highlights

Treatment Research

4 treatments under study, led by Avatrombopag Maleate

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Phase 4 (2)

Trial Status

Unknown3

Clinical Trials (3)

Showing 3 of 3 trials
NCT05944445UnknownPrimary

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT

NCT04915287Phase 4UnknownPrimary

Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

NCT04845659Phase 4UnknownPrimary

Avatrombopaq In Patients With Cirrhosis

Showing all 3 trials

Research Network

Common Treatments

  • Avatrombopag Maleate2
  • Medicine1
  • Linezolid1
  • Platelet Transfusion1

Active Sponsors

  • Helwan University1
  • Hvidovre University Hospital1
  • Chinese PLA General Hospital1

Top Investigators

Related Conditions

  • Chronic Liver Disease1
  • Cirrhosis Liver1
  • Procedural Bleeding1

Activity Timeline